RE:RE:RE:RE:RE:RE:RE:INTERESTING ARTICLE RE LIPID MANAGEMENT , DOSING START Hi G1945V. You are a very active poster and digger. Very helpful. Thanks.
So based on your perspective that rvx-208 would require FDA certification to give credibility to a Zenith sub-IPO then there won't be any Zenith sub-IPOs until about 2017 at best.... 12 month pagse 2c trial, 5 months analysis, 6 months to finds funding for phase 3 trials and then a year or 2 in phase 3.
I'm sure competitors will bury Zenith by then. I can't do anything about my Zenith shares so I guess I'll sit and wait with my fingers crossed. There must be some value in their patents.
On the RVX side I'm assuming that the silence suggests they are working hard at a deal to fund phase 2c. I'm going to hold my RVX position for a month and take stock then.
I'm sensing that inspite of the great scientific and health benefit news I can probably pull back my position in RVX for a year or so and then buy back in as good news begins to develop. PMWP (prove me wrong please) because we all want RVX to kick forward but as we've all seen in other sectors it's not necessarily the best product that wins the day.
Cheers
Toinv :)